MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals Limited (ASX:CXS) (NASDAQ:CXSP) announced today that it will deliver a presentation at the 27th Annual Canaccord Adams Global Growth Conference in Boston, Massachusetts. Greg Collier, Ph.D., Chief Executive Officer and Managing Director of ChemGenex, is scheduled to present to leading institutional investment representatives at 10am on Thursday, August 9, 2007, at the InterContinental Boston.
